Tianchang Li

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure

Runlin Gao, Jian Zhang, Liuquan Cheng et al. · Journal of the American College of Cardiology · 2010 · 278 citations

Medicine, Cardiology, Pharmacotherapy +11

High-Performance Personalized Heartbeat Classification Model for Long-Term ECG Signal

Pengfei Li, Yu Wang, Jiang-Chun He et al. · IEEE Transactions on Biomedical Engineering · 2016 · 160 citations

Engineering, Biomedical Engineering, Cardiology +17

XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China

Keji Chen, Dazhuo Shi, Hao Xu et al. · Chinese Medical Journal · 2006 · 65 citations · Full text

Medicine, Cardiology, Pharmacology +14

Prevalence of Symptomatic Congenital Heart Disease in Tibetan School Children

Jianyong Zheng, Hai-Tao Tian, Zhiming Zhu et al. · The American Journal of Cardiology · 2013 · 39 citations

Medicine, Cardiology, Pediatrics +12